русский 
Kreyòl Ayisyen
Gaeilgenah Éireann
Norsk
Srbija jezik (latinica)
bosanski
Português
Français
magyar
বাংলা
Polski
Table of contents
2. Introduction to VP/VA copolymers
3. Mechanism of action of drug sustained-release carriers
4. Factors affecting drug release rate
5. Research status and latest progress
6. Challenges and future prospects
In the biomedical field, precise drug delivery and sustained stable release have always been the focus and hotspot of research. As a high-performance polymer material, VP/VA copolymer has shown great application potential in drug sustained-release carriers due to its unique chemical structure and good biocompatibility. In-depth exploration of the regulatory factors of drug release rate when it is used as a drug sustained-release carrier is of great significance for optimizing drug treatment effects, reducing drug side effects, and promoting the development of new drug preparations.
2. Introduction to VP/VA copolymers
1. Structure and properties
VP/VA copolymer is a high molecular weight polymer generated by copolymerization of N-vinyl pyrrolidone (VP) and vinyl acetate (VA). The VP unit in its molecular chain gives the copolymer good hydrophilicity and biocompatibility, while the VA unit affects the hydrophobicity and mechanical properties of the copolymer. This unique structure enables VP/VA copolymer to exhibit a variety of physical and chemical properties under different environmental conditions, laying the foundation for its application in the field of drug sustained release.
2. Advantages in biomedical applications
VP/VA copolymer has the advantages of low toxicity, good film-forming properties and degradability, and has attracted much attention in the biomedical field. As a drug sustained-release carrier, it can effectively encapsulate drugs to prevent premature release or rapid metabolism of drugs in the body, thereby improving the utilization rate and therapeutic effect of drugs. At the same time, its degradability allows the carrier to gradually decompose and be metabolized and excreted by the human body after completing the drug release task, reducing potential harm to the human body.
3. Mechanism of action of drug sustained-release carriers
Drug loading method of carrier
VP/VA copolymer is used as a drug sustained-release carrier. Common drug loading methods include physical encapsulation and chemical covalent bonding. Physical encapsulation is to directly encapsulate the drug inside the nanoparticles or microspheres formed by the copolymer, and slowly release the drug through diffusion; chemical covalent bonding is to use the active groups on the copolymer molecular chain to react chemically with the drug molecules to form a stable covalent bond, and the drug is released by breaking the chemical bond. Different loading methods have a significant effect on the drug release rate.
Basic principles of drug release
The release of drugs from VP/VA copolymer carriers is mainly based on mechanisms such as diffusion, dissolution and enzymolysis. Diffusion refers to the diffusion of drugs from the inside of the carrier to the external environment under the action of concentration gradient; dissolution is the release of drugs as the carrier gradually dissolves in the body environment; enzymolysis is the degradation of the carrier under the action of specific enzymes, thereby releasing the drug. In practical applications, drug release is often the result of the combined action of multiple mechanisms.
4. Factors affecting drug release rate
●Composition and structure of copolymers
(1.) Ratio of VP to VA: The increase of VP content will increase the hydrophilicity of copolymers, making the carrier easier to absorb water and swell, thereby accelerating the release rate of drugs; on the contrary, the increase of VA content will enhance the hydrophobicity of copolymers and slow down the release of drugs.
(2.) Molecular weight and molecular weight distribution: The carrier structure formed by VP/VA copolymers with higher molecular weight is more compact, the drug diffusion path is longer, and the release rate is relatively slow; while when the molecular weight distribution is wider, it may cause the carrier structure to be uneven, affecting the stability of drug release.
(3.) Chain segment arrangement and crystallinity: The chain segment arrangement and crystallinity of copolymers will also affect drug release. The region with higher crystallinity has a compact structure, which makes it difficult for drugs to diffuse through, which will reduce the drug release rate; while the amorphous region is conducive to the diffusion and release of drugs.
● Interaction between drugs and carriers
(1.) Physical interaction: The physical interaction between drugs and VP/VA copolymers, such as hydrogen bonds and van der Waals forces, will affect the solubility and diffusion rate of drugs in the carrier. Stronger physical interactions will make the drug and carrier bind tightly, delaying drug release; on the contrary, it will promote drug release.
(2.) Chemical interaction: When the drug and the copolymer are bound by chemical covalent bonds, the release of the drug depends on the breaking speed of the chemical bond. Different chemical bond types and bond energy determine the speed of drug release. For example, ester bonds are relatively easy to hydrolyze in the body environment, and the release rate of drugs connected by ester bonds may be faster.
●Carrier morphology and size
(1.) Nanoparticles and microspheres: The size of nanoparticles and microspheres made of Vinylpyrrolidone-Copolymer as drug carriers has a significant effect on the drug release rate. Smaller nanoparticles have a larger specific surface area, making it easier for drugs to contact the external environment and releasing them faster; while microspheres have a longer drug diffusion path due to their larger size, and the release is relatively slow.
(2.) Porous structure: VP/VA copolymer carriers with porous structures can increase the drug loading and provide more channels for drug diffusion, thereby accelerating the drug release rate. The size, shape and uniformity of the pores will affect the drug release behavior.
● Environmental factors
(1.) pH value: The pH value in different parts of the body is different, and the degradation rate and drug release rate of VP/VA copolymers will be affected by the environmental pH value. For example, in an acidic environment, some chemical bonds in the copolymer may be more easily hydrolyzed, resulting in faster carrier degradation and increased drug release rate.
(2.) Temperature: Changes in body temperature will also have a certain effect on drug release. Generally speaking, an increase in temperature will speed up the movement of molecules, promote the diffusion of drugs and the degradation of carriers, thereby increasing the drug release rate. However, in actual applications, body temperature is relatively stable, and the effect of temperature on drug release is relatively small.
(3.) Presence of enzymes: There are many enzymes in the body, such as esterases and proteases, which can specifically act on VP/VA copolymers, accelerate the degradation of carriers, and then regulate the release rate of drugs. The activity and concentration distribution of different enzymes will lead to different drug release rates in different tissues and organs.
5. Research status and latest progress
● Experimental research results
Recently, a number of studies have explored the performance of VP/VA copolymer drug sustained-release carriers through experimental means. [Research team name 1] prepared copolymer microspheres with different VP/VA ratios by emulsion polymerization and loaded anticancer drugs for in vitro release experiments. The results showed that with the increase of VP content, the drug release rate was significantly accelerated, and the cumulative drug release within 48 hours increased from 30% to 70%. [Research team name 2] studied the effect of changing the molecular weight of the copolymer and the particle size of the carrier on the drug release rate. It was found that both the reduction of molecular weight and the reduction of particle size can significantly increase the drug release rate, and under simulated physiological environment, the drug release showed good controllability.
●Simulation and computational research
In addition to experimental research, simulation and computational methods have also been widely used in the study of VP/VA copolymer drug sustained-release carriers. [Research team name 3] used molecular dynamics simulation methods to study the interaction between drugs and copolymers and the diffusion behavior of drugs in the carrier. By simulating the drug release process under different conditions, the quantitative relationship between drug release rate and copolymer structure and drug-carrier interaction was revealed, providing a theoretical basis for optimizing carrier design.
6. Challenges and future prospects
●Challenges
(1.) Complexity of precise regulation: Although many factors that affect drug release rate have been identified, there are still many challenges to achieve precise and personalized regulation of drug release rate. The interactions between different factors are complex, and it is difficult to establish an accurate mathematical model to predict and control drug release behavior.
(2.) In vitro and in vivo correlation: There is a large difference between in vitro experimental conditions and in vivo physiological environment. How to establish an effective in vitro and in vivo correlation model to ensure that in vitro experimental results can accurately reflect the in vivo drug release is one of the key issues that need to be solved.
(3.) Large-scale production and quality control: The large-scale production technology of VP/VA copolymer drug sustained-release carriers is not yet mature, the production cost is high, and the stability and consistency of product quality are difficult to guarantee, which limits its clinical application and commercial promotion.
● Future prospects
(1.) Intelligent carrier design: With the continuous development of materials science and biotechnology, it is expected that intelligent VP/VA copolymer drug sustained-release carriers will be developed in the future, which can automatically adjust the drug release rate according to changes in the in vivo environment (such as pH, temperature, enzyme concentration, etc.), and achieve precise drug delivery and personalized treatment.
(2.) Multidisciplinary integration: Strengthen the cross-integration of multiple disciplines such as materials science, medicinal chemistry, and biomedical engineering, and comprehensively apply various advanced technologies and methods to deeply study the performance and mechanism of action of VP/VA copolymer drug sustained-release carriers, and provide new ideas and methods for solving current problems.
(3.) Clinical transformation and application: Increase investment in clinical research on VP/VA copolymer drug sustained-release carriers, promote its transformation from laboratory research to clinical application, provide patients with safer and more effective drug treatment plans, and benefit human health.
VP/VA copolymer is a drug sustained-release carrier material with broad application prospects. Its drug release rate is regulated by many factors. In-depth research on these factors is of great significance for optimizing carrier performance and improving drug treatment effects. Although research in this field has made certain progress, it still faces many challenges. Through continuous innovation and multidisciplinary cooperation, it is expected to overcome these challenges, promote the widespread application of VP/VA copolymer drug sustained-release carriers in the biomedical field, and make greater contributions to the treatment of diseases and human health.